Travelers Announces the Start of the 2025 Travelers Championship
HARTFORD, Conn.--(BUSINESS WIRE)--The Travelers Companies, Inc. (NYSE: TRV) today announced the start of the 2025 Travelers Championship at TPC River Highlands in Cromwell, Connecticut, the final Signature Event of the PGA TOUR season. This year's tournament marks Travelers' 19th consecutive year as title sponsor, making the company the longest-running title sponsor in the event's history.
The 2025 Travelers Championship features the top 10 players in the Official World Golf Ranking, and 45 of the top 50. Players include Scottie Scheffler, the No. 1 player in the world and the tournament's defending champion; Rory McIlroy (No. 2); Xander Schauffele (No. 3); Collin Morikawa (No. 4); and Justin Thomas (No. 5).
'When Travelers first became the title sponsor in 2007, our goal was to make a difference in our community,' said Alan Schnitzer, Chairman and Chief Executive Officer of Travelers. 'We are proud to have done that 19 years running, including three years with an elevated status. After all this time, the Travelers Championship is still a labor of love, made possible with the PGA TOUR's support, the best players in golf, corporate sponsors, community partners, the countless Travelers employees who volunteer their time and, most importantly, the fans. We are looking forward to another great week of golf that will benefit charities throughout the region and generate important economic activity.'
Since Travelers became title sponsor in 2007, the tournament has generated tens of millions of dollars for hundreds of local and regional charities. In 2024, 206 nonprofit organizations benefited from the more than $3.2 million generated by the event.
This year's primary beneficiary will again be The Hole in the Wall Gang Camp, an organization based in Ashford, Connecticut, that provides a traditional summer camp experience for children with serious illnesses. A variety of other charities – focusing on arts and culture, education, health care, housing, human services, mental health, food insecurity, science and technology, and youth development – also benefit from their involvement with the Travelers Championship.
'The longest-running title sponsor in tournament history is not a milestone we take for granted,' said Andy Bessette, Executive Vice President and Chief Administrative Officer at Travelers. 'We are proud to have played a lead role in building this tournament into one of the few Signature Events on the PGA TOUR, and we are grateful to the countless people – Tournament Director Nathan Grube and his staff, our team at Travelers and so many others – who make this event a success year after year. I can't wait to see how the competition unfolds.'
All 72 players in this year's tournament will compete for four rounds, beginning on Thursday, June 19. The Travelers Championship offers a $20 million purse, with $3.6 million going to the winner.
Ticketed spectators will be allowed on-site starting Wednesday, June 18. Tournament-related special events are scheduled throughout the week and include The Umbrella at 15 ½ Challenge on Tuesday, where PGA TOUR players compete in a closest-to-the-pin contest at the 40-foot-wide floating green in the shape of the Travelers red umbrella logo. The winner will earn $10,000 from Travelers for the charity of his choice. The Signature Women's Day Breakfast will be held at TPC River Highlands on Thursday, with Hoda Kotb, award-winning journalist, author and CEO, as the keynote speaker.
Golf Channel will provide live tournament coverage from 3 to 6 p.m. ET Thursday and Friday, and Saturday and Sunday from 1 to 3 p.m. ET. CBS will provide coverage from 3 to 6:30 p.m. ET Saturday and 3 to 6 p.m. ET Sunday. PGA TOUR Live on ESPN+ will offer live access to marquee and featured groups, as well as certain holes, Thursday through Sunday. The event can also be streamed on Paramount+.
For more information about the Travelers Championship, visit TravelersChampionship.com. Fans can also follow the tournament's social media channels on X, Facebook, Instagram, LinkedIn and TikTok for news and information.
About Travelers
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Is It Too Late To Consider Buying Dillard's, Inc. (NYSE:DDS)?
Dillard's, Inc. (NYSE:DDS), is not the largest company out there, but it received a lot of attention from a substantial price increase on the NYSE over the last few months. While good news for shareholders, the company has traded much higher in the past year. As a well-established company, which tends to be well-covered by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. But what if there is still an opportunity to buy? Today we will analyse the most recent data on Dillard's's outlook and valuation to see if the opportunity still exists. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Good news, investors! Dillard's is still a bargain right now. Our valuation model shows that the intrinsic value for the stock is $502.95, but it is currently trading at US$400 on the share market, meaning that there is still an opportunity to buy now. However, given that Dillard's's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility. View our latest analysis for Dillard's Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with an extremely negative double-digit change in profit expected over the next couple of years, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for Dillard's, at least in the near future. Are you a shareholder? Although DDS is currently undervalued, the negative outlook does bring on some uncertainty, which equates to higher risk. Consider whether you want to increase your portfolio exposure to DDS, or whether diversifying into another stock may be a better move for your total risk and return. Are you a potential investor? If you've been keeping tabs on DDS for some time, but hesitant on making the leap, we recommend you research further into the stock. Given its current undervaluation, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. While conducting our analysis, we found that Dillard's has 1 warning sign and it would be unwise to ignore this. If you are no longer interested in Dillard's, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
25 minutes ago
- Yahoo
Boveda's Precision Humidity Control Elevates Herbal Freshness in the New Crumblr Aerator
Boveda technology keeps herbs fresher longer in the innovative Crumblr aerator MINNETONKA, Minn., June 16, 2025--(BUSINESS WIRE)--Boveda, the global leader in precise, reliable 2-way humidity control, is proud to announce its technology is now featured in the Crumblr—a new, user-friendly herbal aerator, humidor, and storage system. The Crumblr is the first device of its kind offered by a third party to integrate Boveda's patented humidity control, ensuring that aerated herbs stay fresher, more potent, and better tasting for longer. With Boveda's 2-way humidity control technology at its core, the Crumblr offers a significant upgrade for anyone who values freshness and quality. Boveda's innovative technology automatically regulates humidity inside the Crumblr, protecting terpenes and extending shelf life. Once herbs are aerated and fluffed, they remain at their peak, preserved against overdrying or moisture damage. "Combining Boveda's 2-way humidity control with the Crumblr is a game-changer in the world of precision grinding," said Boveda's Wholesale Direct Accounts Manager, Mike Kanowitz. "We are delighted that Crumblr recognized the game-changing technology that Boveda delivers by incorporating our product into Crumblr's advanced design." "For rapidly chewing through any quantities of biomass while keeping cannabis fresh with Boveda's unique humidity control, there is no better solution available," Jake Kuczeruk, Budist. "The unique hand-crank mechanism of the Crumblr is revolutionary for medical cannabis users who need convenient, high-quality cannabis, especially those struggling with arthritis." Boveda's inclusion in the Crumblr means users benefit from the same gold-standard humidity control trusted by professionals worldwide. Herbs remain fluffy, aromatic, and potent, with terpenes and flavors preserved for an exceptional experience. Follow this link to see Boveda and the Crumblr in action: ### About Boveda Inc.: Boveda Inc. is the global leader in 2-way humidity control. The brand's suite of products preserve moisture-sensitive items, including cigars, cannabis, medical devices, guitars, and more. Headquartered in Minnetonka, Minnesota, Boveda invented and patented the Original Terpene Shield™, which protects dried cannabis in storage, transport, and packaging. Made with all-natural salts and purified water, Boveda's ready-to-use packs allow moisture to pass in and out as necessary through a semipermeable vapor-phase reverse osmosis membrane. The purified water creates a powerful terpene shield that protects precious trichomes by preventing evaporation and preserving terpenes and other volatile compounds. Innovative companies ensure an exceptional consumer experience by using Boveda to maintain the quality, consistency, and freshness of their moisture-sensitive products. For more information, visit or call 952-745-2900. About Crumblr: Crumblr by Project Epoch LLC is the world's first 3-in-1 humidor, storage container, and aerating grinder. It is designed to preserve the natural quality of herbs while delivering a consistent and effective grind. The device uses a patent-pending dual-blade system with built-in humidity control to gently fluff the material instead of crushing it. Tests show improved burn consistency and product density. Crumblr is founded by a diverse team and is certified as an SBA 8(a) business. It is built for quality, inclusion, and broad use across herbal, culinary, and wellness markets. For more information, visit View source version on Contacts Boveda Inc. Rachel AlbertsonBoveda, Inc.(605) Crumblr media@
Yahoo
32 minutes ago
- Yahoo
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating
Disc Medicine, Inc. (NASDAQ:IRON) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 11, analysts from Raymond James resumed coverage of Disc Medicine, Inc. (NASDAQ:IRON) with a strong Buy rating and a price target of $89. The resumed coverage comes as the company released its research note on Biotech names. The firm highlighted a favorable risk/reward profile in the biotech sector. It noted that while companies with a high probability of success for lead assets inspire higher conviction, investments in less de-risked assets like Disc Medicine, Inc. (NASDAQ:IRON) could yield the most outsized returns. The firm sees more than $1 billion potential for the company's drug bitopertin, with an expected market penetration of about 30%-35%, owing to its disease-modifying agent capabilities X-linked protoporphyria. A scientist in a laboratory setting examining a sample of blood with a microscope. Disc Medicine, Inc. (NASDAQ:IRON) is a clinical-stage biopharmaceutical company focused on discovering therapies for serious hematologic diseases. Its pipeline includes drug candidates like bitopertin for erythropoietic porphyrias and Diamond-Blackfan Anemia, DISC-0974 for anemia related to myelofibrosis and chronic kidney disease, and DISC-3405 for polycythemia vera and other blood disorders. While we acknowledge the potential of IRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
